Editas Medicine News

Editas Medicine Analyst Ratings

BenzingaMar 1 00:56

Barclays Maintains Equal-Weight on Editas Medicine, Raises Price Target to $11

BenzingaFeb 29 21:44

Analysts' Opinions Are Mixed on These Healthcare Stocks: Schrodinger (SDGR), Editas Medicine (EDIT) and MacroGenics (MGNX)

TipRanksFeb 29 15:51

Editas Medicine Analyst Ratings

BenzingaFeb 28 02:01

RBC Boosts Price Target on Editas Medicine to $11 From $8, Keeps Sector Perform Rating

MT NewswiresJan 3 20:59

Truist Securities Maintains Buy on Editas Medicine, Raises Price Target to $20

BenzingaDec 12, 2023 23:13

Editas Medicine Analyst Ratings

BenzingaDec 12, 2023 23:11

Analysts Offer Insights on Healthcare Companies: IN8bio (INAB) and Editas Medicine (EDIT)

TipRanksNov 8, 2023 14:50

Analysts' Opinions Are Mixed on These Healthcare Stocks: Editas Medicine (EDIT), Corvus Pharmaceuticals (CRVS) and AC Immune SA (ACIU)

TipRanksNov 8, 2023 14:41

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Editas Medicine (EDIT) and Revolution Medicines (RVMD)

TipRanksOct 24, 2023 20:21

Editas Upgraded at Citi Ahead of FDA AdCom on Gene Editing Therapy

Seeking AlphaOct 24, 2023 20:05

Citigroup Upgrades Editas Medicine to Buy, Announces $11 Price Target

BenzingaOct 24, 2023 18:21

Editas Medicine Analyst Ratings

BenzingaOct 24, 2023 18:20

Editas Medicine Analyst Ratings

BenzingaOct 18, 2023 17:33

Editas Medicine Analyst Ratings

BenzingaOct 17, 2023 21:16

Editas Medicine Analyst Ratings

BenzingaSep 29, 2023 16:42

Cantor Fitzgerald Reiterates Overweight on Editas Medicine, Maintains $14 Price Target

BenzingaSep 13, 2023 20:25

Editas Medicine Analyst Ratings

BenzingaSep 13, 2023 20:25

Cantor Fitzgerald Reiterates Overweight on Editas Medicine, Maintains $14 Price Target

BenzingaAug 29, 2023 23:40

Editas Medicine Analyst Ratings

BenzingaAug 29, 2023 23:39